Nothing Special   »   [go: up one dir, main page]

IL132848A0 - Treatment of hepatic cirrhosis - Google Patents

Treatment of hepatic cirrhosis

Info

Publication number
IL132848A0
IL132848A0 IL13284898A IL13284898A IL132848A0 IL 132848 A0 IL132848 A0 IL 132848A0 IL 13284898 A IL13284898 A IL 13284898A IL 13284898 A IL13284898 A IL 13284898A IL 132848 A0 IL132848 A0 IL 132848A0
Authority
IL
Israel
Prior art keywords
treatment
hepatic cirrhosis
cirrhosis
hepatic
Prior art date
Application number
IL13284898A
Other versions
IL132848A (en
Original Assignee
Hadasit Medical Res Services
Dev Company Ltd
Israel State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25338371&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL132848(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hadasit Medical Res Services, Dev Company Ltd, Israel State filed Critical Hadasit Medical Res Services
Publication of IL132848A0 publication Critical patent/IL132848A0/en
Publication of IL132848A publication Critical patent/IL132848A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL13284898A 1997-05-23 1998-05-22 Composition for treating hepatic cirrhosis IL132848A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86238297A 1997-05-23 1997-05-23
PCT/US1998/010505 WO1998052514A2 (en) 1997-05-23 1998-05-22 Treatment of hepatic cirrhosis

Publications (2)

Publication Number Publication Date
IL132848A0 true IL132848A0 (en) 2001-03-19
IL132848A IL132848A (en) 2004-08-31

Family

ID=25338371

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13284898A IL132848A (en) 1997-05-23 1998-05-22 Composition for treating hepatic cirrhosis

Country Status (8)

Country Link
EP (1) EP1014988A2 (en)
JP (1) JP2002515905A (en)
KR (1) KR100540537B1 (en)
CN (1) CN1160073C (en)
AU (1) AU748754B2 (en)
CA (1) CA2290502C (en)
IL (1) IL132848A (en)
WO (1) WO1998052514A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003278579A1 (en) * 2002-10-31 2004-05-25 Collgard Biopharmaceuticals Ltd Quinazolinone compositions for regulation of gene expression related to pathological processes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3320124A (en) * 1964-07-20 1967-05-16 American Cyanamid Co Method for treating coccidiosis with quinazolinones
CA2113229C (en) * 1994-01-11 1999-04-20 Mark Pines Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof

Also Published As

Publication number Publication date
WO1998052514A3 (en) 1999-08-19
CN1160073C (en) 2004-08-04
JP2002515905A (en) 2002-05-28
KR100540537B1 (en) 2006-01-10
WO1998052514A2 (en) 1998-11-26
CA2290502A1 (en) 1998-11-26
IL132848A (en) 2004-08-31
EP1014988A2 (en) 2000-07-05
KR20010012838A (en) 2001-02-26
CN1265034A (en) 2000-08-30
AU7692298A (en) 1998-12-11
CA2290502C (en) 2007-08-28
AU748754B2 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
GB2335153B (en) Treatment of water
PL339551A1 (en) Derivatives of rezorcin
HUP0003518A3 (en) Treatment of formaldehyde-containing mixtures
PL334769A1 (en) Derivatives of 5-aroylnaphtene
HUP9902855A3 (en) Preparation of sterol- and stanol-esters
IL132848A0 (en) Treatment of hepatic cirrhosis
ZA985064B (en) Derivatives of pentaerythrits
IL124387A0 (en) Preparation of 5-Methyleneoxazolines
GB2329384B (en) Preparation of 1-chloro-1-cyclopropylethene
PL346528A1 (en) Treatment of depression
PL327430A1 (en) Set of shaped components
GB9721978D0 (en) Treatment of depression
EP1150967A4 (en) Therapeutic compounds and methods
TW319017U (en) Improved structure of mousetraps
TW312301U (en) Improved structure of earmask
PL330386A1 (en) Bathtub
CA84178S (en) Whirlpool
CA84085S (en) Whirlpool
CA79877S (en) Whirlpool bathtub
GB9701448D0 (en) Methods of treatment
GB9708700D0 (en) Treatment of depression
HUP9902845A3 (en) Novel treatment of leptine resistance
GB9724088D0 (en) Treatment of dyskinesia
TW357554U (en) Improvement of shinguards
TW323508U (en) Improved structure of functional hand

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired